Risk factors for pre-eclampsia and their prevalence in Ecuador

Authors

DOI:

https://doi.org/10.35381/s.v.v8i1.3688

Keywords:

Health care (public health), epidemiology and biostatistics, population studies in public health, (Source: DeCS)

Abstract

Objective: to analyze the risk factors for pre-eclampsia and their prevalence in Ecuador. Method: Descriptive observational documentary study. Results and conclusions: Pregnancies in women suffering from pre-eclampsia and Gestational Hypertension increased in recent years, generating a rate of approximately 30% of the population at national level of high-risk pregnancies, i.e. patients between the ages of 20 - 29 years represent 46% of pregnant women with pre-eclampsia, however, However, an alarming fact is that 15% of pregnant adolescents aged 15-19 years have complications due to pre-eclampsia. This increase is due to the lack of knowledge about healthy eating and advice on the appropriate conditions to develop a healthy pregnancy without risk of maternal or fetal death. 

Downloads

Download data is not yet available.

Author Biographies

Camila Dayaneth Mier-Báez, Universidad Regional Autónoma de los Andes, Ibarra, Imbabura, Ecuador

 

Keylla Jassiel Chávez-Guevara, Universidad Regional Autónoma de los Andes, Ibarra, Imbabura, Ecuador

 

Siomara Estefania Vaca-Colcha, Universidad Regional Autónoma de los Andes, Ibarra, Imbabura, Ecuador

 

Nayeli Lizeth Catucuamba-Herrera, Universidad Regional Autónoma de los Andes, Ibarra, Imbabura, Ecuador

 

References

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies [published correction appears in Nat Rev Nephrol. 2019 Jun;15(6):386]. Nat Rev Nephrol. 2019;15(5):275-289. http://dx.doi.org/10.1038/s41581-019-0119-6

Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017;31(12):782-786. http://dx.doi.org/10.1038/jhh.2017.61

Townsend R, Khalil A, Premakumar Y, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019;54(1):16-27. http://dx.doi.org/10.1002/uog.20117

Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022;226(2S):S1211-S1221. http://dx.doi.org/10.1016/j.ajog.2020.10.027

Mahdy ZA, Chin KY, Nik-Ahmad-Zuky NL, Kalok A, Abdul Rahman R. Tocotrienol in Pre-Eclampsia Prevention: A Mechanistic Analysis in Relation to the Pathophysiological Framework. Cells. 2022;11(4):614. http://dx.doi.org/10.3390/cells11040614

Petca A, Miron BC, Pacu I, et al. HELLP Syndrome-Holistic Insight into Pathophysiology. Medicina (Kaunas). 2022;58(2):326. http://dx.doi.org/10.3390/medicina58020326

McNestry C, Killeen SL, Crowley RK, McAuliffe FM. Pregnancy complications and later life women's health. Acta Obstet Gynecol Scand. 2023;102(5):523-531. http://dx.doi.org/10.1111/aogs.14523

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives [published correction appears in Circ Res. 2020 Jan 3;126(1):e8]. Circ Res. 2019;124(7):1094-1112. http://dx.doi.org/10.1161/CIRCRESAHA.118.313276

Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1-33. http://dx.doi.org/10.1002/ijgo.12802

Adorno M, Maher-Griffiths C, Grush Abadie HR. HELLP Syndrome. Crit Care Nurs Clin North Am. 2022;34(3):277-288. http://dx.doi.org/10.1016/j.cnc.2022.04.009

Muñoz-Ortiz E, Velásquez-Penagos JA, Gándara-Ricardo JA, Múnera-Echeverri AG. Alteraciones del embarazo como factores de riesgo cardiovascular [Pregnancy alterations as cardiovascular risk factors]. Rev. Colomb. Cardiol. 2022;29(2):123-130.

Oyaque CEC, Tapia MEM, Oyaque TAC, Torres CEC. Factores de riesgo y predictores de preeclampsia: una mirada al futuro [Risk factors and predictors of pre-eclampsia: a look into the future]. Revista Latinoamericana de Hipertensión. 2018;13(1):6-12.

Silva Rocha AD, Rombaldi Bernardi J, Matos S, et al. Maternal adipose tissue to early preeclampsia risk detection: Is the time to maternal ultrasound beyond fetal evaluation?. J Obstet Gynaecol Res. 2021;47(6):2021-2030. http://dx.doi.org/10.1111/jog.14756

Pétursdóttir Maack H, Sundström Poromaa I, Lindström L, Mulic-Lutvica A, Junus K, Wikström AK. Ultrasound estimated subcutaneous and visceral adipose tissue thicknesses and risk of pre-eclampsia. Sci Rep. 2021;11(1):22740. http://dx.doi.org/10.1038/s41598-021-02208-z

Bhorat I. Pre-eclampsia and the foetus: a cardiovascular perspective. Cardiovasc J Afr. 2018;29(6):387-393. http://dx.doi.org/10.5830/CVJA-2017-039

Lugones Botell M. La importancia de la atención prenatal en la prevención y promoción de salud [The importance of prenatal care in prevention and health promotion]. Revista Cubana de Obstetricia y Ginecología. 2018;44(1):1-3.

Published

2024-02-01

How to Cite

Mier-Báez, C. D., Chávez-Guevara, K. J., Vaca-Colcha, S. E., & Catucuamba-Herrera, N. L. (2024). Risk factors for pre-eclampsia and their prevalence in Ecuador. Revista Arbitrada Interdisciplinaria De Ciencias De La Salud. Salud Y Vida, 8(1), 4–11. https://doi.org/10.35381/s.v.v8i1.3688

Issue

Section

Original breve

Most read articles by the same author(s)